MedPath

Role of Uttarbasti and Kanchanar guggulu in the management of Benign Prostatic Hyperplasia

Phase 3
Conditions
Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptoms
Registration Number
CTRI/2024/02/063041
Lead Sponsor
Dr Pranav Prakash Naikwade
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1) Diagnosed patients of Benign Prostatic Hyperplasia of age group between 45 to 80 years.

2) Uncomplicated BPH

3) Selection will be irrespective of religion, education and socio-economic status.

Exclusion Criteria

1) Prostatitis

2) Patient with prostatic carcinoma

3) Complicated BPH

4) Patients with immunocompromised diseases like uncontrolled Diabetes Mellitus, AIDS, Malignancy and Renalfailure.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To know the reduction in the volume of Prostate along with post void residual volume.Timepoint: Duration of study will be of 2 months.
Secondary Outcome Measures
NameTimeMethod
Study the effect on outflow obstruction by means of Uroflowmetry before anf after treatment.Timepoint: Follow up will be taken at 15th, 30th, 45th and 60th day.
© Copyright 2025. All Rights Reserved by MedPath